Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-29

Clinical Trial Update: Effect of the Alpha-galacto-oligasaccharides on Weight Loss in Overweight or Moderately Obeses Adults : A Randomized Controlled Double Blinded Trial Versus Placebo [NA]

View source ↗

Summary

A randomized, double-blind, placebo-controlled trial evaluated alpha-galacto-oligosaccharides for weight loss in overweight or moderately obese adults. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alpha-galacto-oligosaccharides (alpha-galacto-oligosaccharides)

Snippet

Sponsor: Olygose | Conditions: Randomized Versus Placebo, Controlled | NA | Status: COMPLETED